Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Recruitment Information

Read about the recruitment information for a current clinical trial being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed. Or read about patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 42
Study Start Date: August 2006
Estimated Study Completion Date: August 2008

Arms and Assigned Interventions:
1: Experimental
Cisplatin + Imatinib Mesylate + Pemetrexed
Drug: Cisplatin
60 mg/m^2 IV Over 2 Hours
Drug: Imatinib Mesylate
300 mg PO Once Daily
Drug: Pemetrexed
500 mg/m^2 IV Over 40 Minutes

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney